Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • CORRESPONDENCE

Virus variants: GISAID policies incentivize surveillance in global south

By
  1. Jeremy P. Kamil

    1. Louisiana State University Health Shreveport, Shreveport, Louisiana, USA; on behalf of 9 signatories.

Access through your institution
Buy or subscribe

When SARS-CoV-2 coronavirus genome sequences determined in low-income nations are rapidly shared through the independent Global Initiative on Sharing Avian Influenza Data (GISAID), attention and collaboration flow in from scientists at prestigious institutes (see, for example, go.nature.com/3upedvz). This helps to highlight education and health-security inadequacies in less-wealthy countries.

Access options

Access through your institution

Rent or buy this article

Prices vary by article type

from$1.95

to$39.95

Learn more

Prices may be subject to local taxes which are calculated during checkout

Nature 593, 341 (2021)

doi: https://doi.org/10.1038/d41586-021-01310-6

A full list of co-signatories to this letter appears in Supplementary Information.

Supplementary Information

  1. List of co-signatories

Competing Interests

V.S.C. is an adviser and co-founder of Microbial Genome Sequencing Center, LLC. J.P.K. is a consultant for BioNTech.

Nature Careers

Jobs

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing

Search

Advanced search

Quick links